Is It Mold, Lyme, COVID, or Autoimmune?
Patients labeled with Lyme, mold illness, long COVID, or autoimmune disease often share the same symptoms: fatigue, brain fog, dizziness, and unresolved inflammation. This post argues that chasing a single trigger misses the real pattern — a gut-trained immune system that has lost its ability to regulate itself. It walks through how molecular mimicry, epitope spreading, EBV reactivation, and strep-related antibodies can push the immune system toward attacking the body's own tissue and brain, and why short chain fatty acids like butyrate are central to resetting that regulation. The piece closes with a reframe: instead of asking which diagnosis fits, ask what's keeping the immune system stuck on "attack," and how long it's been running.

Is It Mold, Lyme, COVID, or Autoimmune?
That is the question everyone is asking. I think the premise is wrong.
For a long time, I looked for the one trigger.
A patient would come in with years of fatigue, brain fog, dizziness, and inflammation that nobody could explain. I would take a careful history and I would find something. An old tick bite. A water damaged house. A virus that took months to shake instead of weeks. I would treat what I found. The patient would improve, then stall. Months later, they would lose the ground they gained.
For years I assumed that meant I had missed something, so I looked harder. And I kept finding things, because in these patients there is always something else to find.
That was the clue, and it took me too long to see it. The problem was not that I was missing the trigger. The problem was that I was looking for one.
The label changes. The patient does not.
For years, chronic illness was blamed on Lyme disease. Then attention shifted to mold. After 2020 it
became long COVID. Now the conversation is turning again, toward autoimmunity.
Let me be clear. Lyme is real. Mold illness is real. Long COVID is real. Each is the correct answer for some patients, and for those patients, treating the trigger is what should happen.
But the presentation in my office has not changed in eighteen years. Exhausted. Foggy. Dizzy on standing. Sensitive to light and sound. Inflamed. Unable to recover from ordinary stress. Only the diagnosis attached to it changes, and it changes with whatever the field is paying attention to that decade.
And when I take a full history on these patients, I almost never find one event. I find a series. Strep infections in childhood. A concussion nobody thought much about. Years of poor sleep. A gut that never recovered after antibiotics. A virus that lingered. A water damaged apartment. Then COVID.
No single item on that list explains a chronic illness. But they do not arrive in isolation. They accumulate, and the immune system never gets a full reset in between.
The immune system is trained in the gut
Two systems are involved here, and they are not separate.
The brain has direct control lines into immune function. It signals through the vagus nerve, which can raise or lower inflammation, and through stress hormones that change how immune cells behave.
Inflammatory signals travel back up and change how the brain works. It is one loop.
And that immune system has to be taught. It is not born knowing the difference between you and a threat. It learns that in the gut, where most of your immune cells live and where they are introduced, over a lifetime, to food, to bacteria, and to your own tissue.
So a gut that has been disordered for years is not simply uncomfortable. It is an immune system that has been trained badly, every day, for years. Eventually it makes the error it is built to avoid. It stops reliably telling you from a threat.
How an immune response to one infection becomes autoimmunity
This is the question I get asked most, and it deserves a direct answer. Here is the sequence.
Step one. You get an infection. Your immune system builds antibodies shaped to fit that specific germ. This is normal and correct.
Step two. Some germs carry surface proteins that are shaped like proteins in your own tissue. The antibody fits both. This is called molecular mimicry, and it is a single, specific error. It happens more often than people realize.
Step three. In an immune system with intact regulation, this gets shut down. Regulatory cells recognize the mistake and suppress the response. It is self-limiting, and most people never know it happened.
Step four. If regulation is weak, nothing shuts it down. The antibodies stay. They keep binding your tissue. That produces low-grade inflammation and slow damage in whatever tissue they fit.
Step five. Damaged cells break open. Proteins that are normally sealed inside a cell spill into the open. Your immune system has never been introduced to most of them, and was never trained to tolerate them.
Step six. In an inflamed environment, those newly exposed proteins get read as threats. New antibodies form against them. These new antibodies have nothing to do with the original infection.
Step seven. Repeat. Each round of damage exposes more material. The list of targets grows. One target becomes three. Three becomes eight.
Immunologists call step seven epitope spreading. The concept is not mine.
But notice where the whole sequence turns. It turns at step three. In a regulated immune system, a mimicry error is a passing accident. In a poorly regulated one, it becomes a permanent condition. And regulation is trained in the gut.
That is why a widening antibody response tells me something specific. It tells me the training ground has been failing for a long time.
Epstein-Barr: the virus that lives inside the antibody factory
Almost everyone carries Epstein-Barr virus, and that is exactly why it gets dismissed. It should not be.
What makes EBV different from most viruses is where it lives. It infects B cells. B cells are the cells that produce antibodies. The virus takes up residence inside the part of the immune system responsible for the antibody response itself.
It stays for life. Your immune system has to actively hold it down, every day, and that containment requires good regulation. When regulation slips, EBV reactivates.
A reactivated EBV drives B cell activation, including B cells that produce antibodies against your own tissue. And one of its proteins, EBNA1, is shaped closely enough like a protein in the brain's glial cells that antibodies raised against the virus can bind brain tissue. That resemblance has been structurally demonstrated, not just suspected.
The scale of this matters. In a study following millions of people, EBV infection raised the risk of multiple sclerosis roughly thirty-two fold, and researchers now describe it as the leading cause of that disease.
I want to be careful here, because it would be easy to replace one single culprit with another. EBV is rarely where these illnesses start. It is where they end up. It is already inside almost all of us, so when regulation slips for any reason, whether from Lyme, a gut inflamed for a decade, mold, or COVID, it is often the first thing to come back. And once it is back, it becomes a driver in its own right, not just a marker.
Strep: antibodies that do not just bind, they signal
Group A strep is a common childhood infection, and it is the clearest example of how this process reaches the brain.
Strep carries surface proteins shaped like proteins in the basal ganglia, the brain region that governs movement, habit, and emotional regulation. Antibodies raised against the infection can cross-react with dopamine receptors there, and with structural proteins in the neuron such as tubulin.
Here is the part that matters most. Those antibodies do not simply stick to the receptor. They signal through it. When they bind, they activate the receptor's internal machinery and change dopamine release. They are not passive. They are pressing the button.
The result is a recognized neuropsychiatric picture: obsessive thoughts, tics, anxiety, restlessness, and subtle movement changes. It is documented in the medical literature, in Sydenham chorea and in the PANDAS research.
What I see clinically is the slower version. A young person with several strep infections at twelve. Anxiety from thirteen to fifteen that gets called a phase. Chronic headaches at eighteen, sometimes with mild movement findings on examination that no one has connected to anything.
Nobody links those events, because they are years apart and nothing in a standard workup spans that gap.
Why the brain becomes the target
For antibodies to damage the brain, two things must be true. They have to exist, and they have to reach it.
The blood brain barrier normally keeps antibodies out. But that barrier depends on signals from the gut, and it loosens when inflammation is high and those signals are low.
Once antibodies get in, they bind neural targets. The immune complexes they form activate microglia, the brain's own immune cells, which then produce inflammation inside the brain itself. That inflammation damages neural tissue. Damaged neural tissue exposes more neural protein. And now the spreading process is running against brain targets specifically: myelin, receptors, structural proteins.
At that point the brain is no longer a bystander in an immune problem. It has become the site of it.
COVID is what finally proved it
For most of my career this was difficult to demonstrate, because there was never a clean starting line.
Patients described a decline that began somewhere in a fog of years, and without a clear before and after it was easy to call it stress.
Then millions of people received the same immune insult on a known date.
When researchers examined what predicted who would go on to develop long COVID, two of the factors they identified early in the infection were these: autoantibodies, meaning the immune system had begun attacking the person's own tissue, and Epstein-Barr virus in the bloodstream, meaning a dormant virus had reactivated.
Those are the same two events I have just described. The people who did not recover were the ones whose immune systems had lost regulation and reactivated an old virus.
Researchers still debate how much of the ongoing illness the reactivated virus is causing, and that question is not settled. Clinically it changes little. A reactivated virus tells me the immune system has lost its grip, whether it is driving the illness or reporting it.
Breadth is a clock
The widening response has one property that changed how I practice. It takes time.
Building antibodies against many different targets does not happen in a few months. It takes repeated cycles of damage and inflammation, over years. So the number of targets a person has acquired is not only a measure of how sick they are. It is a record of how long this has been running.
That means an immune panel can be read as a history. A narrow response suggests something recent.
A broad response, spread across several systems at once, tells me the process is established, self-sustaining, and will not resolve in six weeks regardless of the protocol. It is not a stopwatch and I would not oversell it. But it is the most useful thing I can know before building a plan.
The dial, and the signal that sets it
The immune system is not on or off. It is a dial. At one end it attacks and inflames. At the other it resolves, repairs, and holds itself back from healthy tissue. A functioning immune system moves along that dial and returns. My patients cannot return.
What holds the dial in place is largely produced in the colon.
When gut bacteria ferment fiber, they produce short chain fatty acids, mainly butyrate, acetate, and propionate. Butyrate is the primary fuel for the cells lining the colon. It supports the regulatory cells that hold the immune system back from attacking you. And it moves the dial toward repair.
When butyrate runs low, three things happen together. The gut lining loses its fuel. The regulatory cells lose their support. And the dial drifts toward inflammation and stays there. I see short chain fatty acid depletion, minor or severe, in nearly every complex patient who comes to my office.
This is also where the gut reaches the brain directly. In animal research, mice raised without gut bacteria develop microglia that never mature properly, and supplying nothing but the three short chain fatty acids was enough to mature them. The same work shows the protective barrier around the brain becomes leaky without gut bacteria, and that butyrate helps restore it. That research is largely done in animals and I will not claim it is settled in humans. But the direction is consistent, and it matches what I see clinically.So the chain runs like this. The microbes go quiet. Butyrate falls. The gut wall weakens and immune regulation degrades. The dial sticks toward attack. Mimicry errors are no longer shut down. The barrier protecting the brain loosens. Antibodies reach neural tissue. Microglia activate. And the spreading process begins running against the brain.
That is how a disordered colon produces brain fog, headaches, visual problems, dizziness, digestive symptoms, fatigue, and frequent illness. Patients arrive believing these are six separate problems, often with six specialists to match. It is usually one problem producing six symptoms.
The long answer and the short answer are not the same
The long term answer is the gut ecosystem. Nothing else is durable. If the microbes that produce your butyrate are depleted, then every anti-inflammatory measure you take is temporary. You improve while you take it and lose ground when you stop, because the signal that sets your immune dial is still not being produced. Rebuilding that ecosystem over months is the only thing that changes the setting permanently.
But the short term answer cannot be to wait. You cannot tell a patient with an inflamed brain to eat more fiber and return in a year. So while the ecosystem is being rebuilt, two things run alongside it.
The immune system receives direct modulation, bringing the inflammatory tilt down while the gut is repaired underneath it. And the brain is worked directly, because a brain that has been compensating badly for a decade does not reorganize itself simply because inflammation came down.
Both arms, at the same time, in the right order. Most of my patients have already tried aggressive interventions. Their problem was rarely intensity. It was sequence. Doing the right things in the wrong order is the most common reason a previous attempt stalled, and it is why so many of them have a history of protocols that worked for six weeks.
The question that actually matters
Stop asking which door you came through. It is worth knowing, and sometimes the trigger is the whole story and treating it works.
But if you have been sick for years and have tried everything, these are the better questions. What setting is your immune system stuck on. What is holding it there. And how far has the response already spread.
Those are measurable. And the answers tell us not only what to do, but in what order, and for how long.
Ready to feel like you again?
* Your next step toward feeling better starts today. At The Dearing Clinic we make it simple to get started with care that truly fits your life. Book your visit now and let’s design a plan that restores your energy, relieves your pain, and helps you enjoy more of what matters most.

